Volteri Use In Pregnancy & Lactation

Volteri Tablets should not be administered to pregnant women or women who may be pregnant. If pregnancy is detected during treatment, this drug should be discontinued immediately.
a. In patients with hypertension who were given angiotensin II receptor antagonists including candesartan cilexetil or angiotensin converting enzyme inhibitors in the second and third trimesters of pregnancy, it has been reported that oligohydramnios, fetal and neonatal death, neonatal hypotension, renal failure, hyperkalemia, cranial hypoplasia and the following events those are supposed to be due to oligohydramnios, cranial hypoplasia, limb contractures, craniofacial deformation and lung hypoplasia etc. occurred.
b. It has been reported that gestation period and duration of delivery are prolonged when amlodipine besilate is administered in the third trimester of pregnancy in animal studies.
Volteri Tablets should not be administered to nursing mothers. If indispensable, however, the patient should be instructed to discontinue lactation.
a. It has been reported that amlodipine besilate transfers to human mother's milk.